JSW
HURA

Journey Strategic Wealth’s TuHURA Biosciences HURA Stock Holding History

Journey Strategic Wealth’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.4K Buy
10,865
+856
+9% +$1.05K ﹤0.01% 819
2025
Q4 		$7.57K Buy
+10,009
New +$19.2K ﹤0.01% 762

Other funds holding HURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $6.15B AUM 22.62% 1-Year Est. Return

Journey Strategic Wealth's HURA Position: Q1 2026 in Review

Journey Strategic Wealth increased its TuHURA Biosciences (HURA) stake by 8.6% in Q1 2026, buying an estimated $1.05K and bringing the position to 10,865 shares worth $19.4K. The position accounts for ﹤0.01% of the portfolio, ranked #819.

Journey Strategic Wealth first reported a position in HURA in Q4 2025 and has held it in 2 quarters since. 89 funds tracked by Wall St. Rank hold HURA as of Q1 2026.

  • Journey Strategic Wealth held 10,865 shares of TuHURA Biosciences worth $19.4K as of Q1 2026.
  • Journey Strategic Wealth bought 856 TuHURA Biosciences shares in Q1 2026, an estimated $1.05K.
  • TuHURA Biosciences made up ﹤0.01% of Journey Strategic Wealth's portfolio in Q1 2026, its #819 holding.
  • Journey Strategic Wealth first reported a position in TuHURA Biosciences in Q4 2025 and has held it in 2 quarters since.
  • 89 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q1 2026.

Based on Journey Strategic Wealth's 13F filing for Q1 2026, filed 15 Apr 2026.